Analysis of the chemical structure of Gefapixant Citrate
Gefapixant Citrate (Gefapixant Citrate) is a new drug mainly used to treat chronic coughs, especially those caused by respiratory allergies or other mechanisms. It inhibits the cough reflex by targeting the P2X3 receptor, providing an innovative treatment approach.
The chemical name of Gemfapixin is "Gefapixin Citrate", and its chemical structure is composed of complex organic molecules. It is a small molecule drug that is a P2X3 receptor antagonist. The P2X3 receptor is a ATP gated ion channel that is widely distributed in the nervous system, especially in the sensory nerve endings located in the airways. By analyzing the structural formula of Gemfapixin, it can be seen that it blocks the transmission of ATP signals by binding to P2X3 receptors, thereby inhibiting the cough reflex triggered by this signal.
Judging from the chemical structure of Gemfapixin, it contains an imidazole structure combined with other functional groups. The imidazole ring in the Gemfapixin molecule is a five-membered nitrogen heterocycle with extremely high affinity, allowing it to accurately bind to the P2X3 receptor. In addition, the molecule of Gemfapixin also contains chlorine atoms and multiple nitrogen atoms. The introduction of these elements enhances the stability of its molecules and its targeting effect in the body.
Its molecular formula is C14H16ClN5O3, and its molecular weight is approximately 345.77 g/mol. The molecular structure of Gemfapixin is designed to provide high selectivity and the ability to precisely bind to P2X3 receptors while reducing interactions with other receptors or biomolecules. This high degree of selectivity is a major advantage of Gemfapixin, helping to reduce side effects and improve treatment effectiveness.
In terms of its mechanism of action, Gemfapixin binds to the P2X3 receptor and inhibits the binding of ATP to the receptor, thereby reducing the cough signal transmitted by the C fiber nerve. This mechanism of action is a new way to treat chronic cough, especially those caused by respiratory allergies.
References: https://synapse.patsnap.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)